These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 22834671)

  • 21. Successful mirtazapine treatment of an 81-year-old patient with syndrome of inappropriate antidiuretic hormone secretion.
    Jagsch C; Marksteiner J; Seiringer E; Windhager E
    Pharmacopsychiatry; 2007 May; 40(3):129-31. PubMed ID: 17541890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain-derived neurotrophic factor gene polymorphisms and mirtazapine responses in Koreans with major depression.
    Kang RH; Chang HS; Wong ML; Choi MJ; Park JY; Lee HY; Jung IK; Joe SH; Kim L; Kim SH; Kim YK; Han CS; Ham BJ; Lee HJ; Ko YH; Lee MS; Lee MS
    J Psychopharmacol; 2010 Dec; 24(12):1755-63. PubMed ID: 19493959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
    Blier P; Gobbi G; Turcotte JE; de Montigny C; Boucher N; Hébert C; Debonnel G
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):457-65. PubMed ID: 19345072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mirtazapine induced mania in a woman with major depression in the absence of features of bipolarity.
    Basavraj V; Nanjundappa GB; Chandra PS
    Aust N Z J Psychiatry; 2011 Oct; 45(10):901. PubMed ID: 21692606
    [No Abstract]   [Full Text] [Related]  

  • 25. Mania associated with mirtazepine treatment and mixed depression.
    Habermeyer B; Bayer U; Müller-Spahn F
    Pharmacopsychiatry; 2010 Jan; 43(1):37-8. PubMed ID: 20178094
    [No Abstract]   [Full Text] [Related]  

  • 26. Depressive illness in Parkinson's disease--indication of a more advanced and widespread neurodegenerative process?
    Pålhagen SE; Carlsson M; Curman E; Wålinder J; Granérus AK
    Acta Neurol Scand; 2008 May; 117(5):295-304. PubMed ID: 18279483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Optimizing antidepressant pharmacotherapy in a case of inflammatory bowel disease and major depression].
    Schmidt FM; Tennert C; Teupser D; Himmerich H
    Psychiatr Prax; 2012 Jul; 39(5):239-42. PubMed ID: 22689282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mirtazapine: not a dual action antidepressant?
    Gillman PK
    Aust N Z J Psychiatry; 2004 Apr; 38(4):266-7. PubMed ID: 15038808
    [No Abstract]   [Full Text] [Related]  

  • 29. Mirtazapine-induced hepatocellular-type liver injury.
    Kang SG; Yoon BM; Park YM
    Ann Pharmacother; 2011 Jun; 45(6):825-6. PubMed ID: 21666084
    [No Abstract]   [Full Text] [Related]  

  • 30. Dysthymic disorder: treatment with mirtazapine.
    Dunner DL; Hendrickson HE; Bea C; Budech CB; O'Connor E
    Depress Anxiety; 1999; 10(2):68-72. PubMed ID: 10569129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mirtazapene: a noradrenergic and specific serotonergic antidepressant.
    Gray R
    Ment Health Care; 1998 Mar; 1(7):233-4. PubMed ID: 9791425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease.
    Meco G; Bernardi S
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):311-3. PubMed ID: 16919377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mirtazapine--a new antidepressant.
    Med Lett Drugs Ther; 1996 Dec; 38(990):113-4. PubMed ID: 8988154
    [No Abstract]   [Full Text] [Related]  

  • 34. Antidepressive effect of mirtazapine in post-myocardial infarction depression is associated with soluble TNF-R1 increase: data from the MIND-IT.
    Tulner DM; Smith OR; Schins A; de Jonge P; Quere M; Delanghe JR; Crijns HJ; den Boer JA; Korf J; Honig A
    Neuropsychobiology; 2011; 63(3):169-76. PubMed ID: 21228609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case in which mirtazapine reduced auditory hallucinations in a patient with Parkinson disease.
    Nagata T; Shinagawa S; Tagai K; Nakayama K
    Int Psychogeriatr; 2013 Jul; 25(7):1199-201. PubMed ID: 23195073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mirtazapine acutely inhibits salivary cortisol concentrations in depressed patients.
    Laakmann G; Hennig J; Baghai T; Schüle C
    Ann N Y Acad Sci; 2004 Dec; 1032():279-82. PubMed ID: 15677428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mirtazapine--the new standard].
    Fortschr Neurol Psychiatr; 1999 Aug; 67(8 Suppl):1-4. PubMed ID: 10511867
    [No Abstract]   [Full Text] [Related]  

  • 38. Mirtazapine as treatment for serotonin syndrome.
    Hoes MJ; Zeijpveld JH
    Pharmacopsychiatry; 1996 Mar; 29(2):81. PubMed ID: 8741027
    [No Abstract]   [Full Text] [Related]  

  • 39. Mirtazapine and ECT combination therapy.
    Farah A
    Convuls Ther; 1997 Jun; 13(2):116-7. PubMed ID: 9253533
    [No Abstract]   [Full Text] [Related]  

  • 40. Mirtazapine does not influence tetrahydrodeoxycorticosterone levels in depressed patients.
    Schüle C; Baghai TC; di Michele F; Eser D; Pasini A; Romeo E; Rupprecht R
    World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):308-13. PubMed ID: 20218794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.